The present post-hoc analyses were aimed at : describing the prevalence of the metabolic syndrome ( MS ) at baseline ; investigating the effect of long-term antihypertensive therapy ( and separately of atenolol and lacidipine ) on MS prevalence ; exploring whether MS at baseline influenced changes in carotid IMT and incidence of cardiovascular events during treatment ; and describing the relations between MS and new cases of diabetes developing during treatment .
